Results 21 to 30 of about 4,273 (136)

Lymphoplasmacytic lymphoma infiltrating both lacrimal glands in a patient with Waldenström's macroglobulinemia

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: To describe a case of Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma with infiltration of both lacrimal glands. Observations: A 63-year-old male with Waldenström's macroglobulinemia was referred to the ophthalmological clinic due to ...
Andreas Vangsted   +3 more
doaj   +1 more source

Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports

open access: yesJournal of Medical Case Reports, 2020
Background Immunoglobulin M multiple myeloma and Waldenström macroglobulinemia are two different hematological diseases with the common finding of an immunoglobulin M monoclonal gammopathy of unknown significance. However, clinical characteristics of the
Simona Elba   +15 more
doaj   +1 more source

Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature

open access: yesCase Reports in Oncological Medicine, 2014
Background. Recent literature has associated hepatitis C virus with the development of non-Hodgkin lymphoma. Hepatitis C virus infection appears to promote lymphoproliferation, providing a plausible mechanism for a causative association; however, despite
Ryan Nipp   +3 more
doaj   +1 more source

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

open access: yesHemaSphere, 2020
. In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (WM) patients ...
Dipti Talaulikar   +17 more
doaj   +1 more source

Concomitant lymphoplasmacytic lymphoma, multiple myeloma, and amyloidosis: A diagnostic and therapeutic challenge

open access: yesClinical Case Reports, 2022
We report a case based on simultaneous occurrence of Waldenström macroglobulinemia, myeloma and amyloidosis as a collision neoplasm. The strangeness and severity of the case presented a diagnostic and therapeutic challenge, which required individualised ...
Candela Ceballos   +7 more
doaj   +1 more source

Cutaneous Macroglobulinosis Presenting as Serpiginous Purpura, a Case Report and Literature Review

open access: yesClinical, Cosmetic and Investigational Dermatology, 2021
Siriorn Sukanjanapong,1 Kumutnart Chanprapaph,1 Suthinee Rutnin,1 Paisan Boonsakan,2 Sulada Pukiat3 1Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Department of Pathology, Faculty of Medicine,
Sukanjanapong S   +4 more
doaj  

Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia

open access: yesHaematologica, 2018
We here describe a novel method for MYD88L265P mutation detection and minimal residual disease monitoring in Waldenström macroglobulinemia, by droplet digital polymerase chain reaction, in bone marrow and peripheral blood cells, as well as in circulating
Daniela Drandi   +20 more
doaj   +1 more source

WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2018
Waldenstrom Macroglobulinemia is a rare lymphoproliferative disorder with distinctive clinical features. Diagnostic and prognostic charactrization in WM significantly changed with the discovery of two molecular markers: MYD88 and CXCR4. Mutational status
Maddalena Mazzucchelli   +4 more
doaj   +1 more source

Primary central nervous system diffuse large B‐cell lymphoma masqueraded as Bing‐Neel syndrome: Steps in management and review of future directions

open access: yesClinical Case Reports, 2021
Bing‐Neel syndrome (BNS) remains a rare complication of Waldenstrom Macroglobulinemia. Given the paucity of this disease, treatment guidelines are based on small clinical trials with limited participants.
Lukas Delasos   +4 more
doaj   +1 more source

Management and long‐term haematological and neurological outcomes of Immunoglobulin M and Waldenström's macroglobulinaemia‐related neuropathy: A single‐centre experience

open access: yesBritish Journal of Haematology, EarlyView.
In this 28‐patient retrospective cohort, rituximab‐based regimens for IgM‐related neuropathy yielded significant, sustained functional and neurological improvements over a 2‐year follow‐up. Furthermore, reductions in serum IgM levels correlated with improved Inflammatory Neuropathy Cause and Treatment disability scores, highlighting the long‐term ...
Maria Gavriatopoulou   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy